
Taiwan's Formosa inks antibody drug conjugate deal with Almac
Taiwan's Formosa inks antibody drug conjugate deal with Almac May 9, 2025 | Friday | News Licensing agreement for ALM-401, a first-in-class bispecific ADC targeting EGFR/ROR1 for the treatment of solid tumours image credit- shutterstock Taiwan- …